• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Peptide receptor radionuclide therapy for neuroendocrine tumours: Standardized and randomized, or personalized?

MS Hofman, RJ Hicks

European Journal of Nuclear Medicine and Molecular Imaging | Published : 2014

DOI: 10.1007/s00259-013-2621-6

University of Melbourne Researchers

Michael Hofman's Profile Picture
Michael Hofman Author

Citation metrics

24Scopus
21Web of Science
28Dimensions

Keywords

Neurosciences
Science & Technology
Radiolabeled Somatostatin Analog
Clinical Research
3202 Clinical Sciences
32 Biomedical and Clinical Sciences
Carcinomas
3 Good Health and Well Being
Survival
6.1 Pharmaceuticals
Precision Medicine
Radiation Oncology
Lu-177-Octreotate
Radiology, Nuclear Medicine & Medical Imaging
Capecitabine
Chemotherapy
Cancer
Phase-Ii
Toxicity
Clinical Trials and Supportive Activities
Life Sciences & Biomedicine

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224